Although the effects of Humanin G on TNF-α in AMD have not been demonstrated before, along similar lines, it has been shown that administration of TNF-α inhibitors such as Adalimumab, a subcutaneous anti-TNF-α drug, in combination with anti-VEGF therapy improves visual acuity [68]. Here, TNF is linked to age-related macular degeneration.